Global Blood Therapeutics, Inc. (GBT)

About Global Blood Therapeutics, Inc. (GBT)

GBT is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT’s lead product candidate is voxelotor (formerly known as GBT440), an oral, once-daily therapy that modulates hemoglobin’s affinity for oxygen, which the – more... 

Claimed Profile
Headquarters
171 Oyster Point Blvd., Suite 300
South San Francisco, CA 94080
Industry
Links
Global Blood Therapeutics, Inc. (GBT) website
YouTube
LinkedIn

Twitter